Detalles de la búsqueda
1.
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy.
Int J Mol Sci
; 21(4)2020 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32085669
2.
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 20(9): 1226-1238, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402321
3.
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.
Lancet Oncol
; 18(4): 545-554, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28238593
4.
Plasma miRNA Levels for Predicting Therapeutic Response to Neoadjuvant Treatment in HER2-positive Breast Cancer: Results from the NeoALTTO Trial.
Clin Cancer Res
; 25(13): 3887-3895, 2019 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30814109
5.
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication.
Ther Adv Med Oncol
; 11: 1758835919833867, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31205497
6.
Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer.
Eur J Cancer
; 118: 169-177, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31377477
7.
Radiation-induced changes in gene expression involve recruitment of existing messenger RNAs to and away from polysomes.
Cancer Res
; 66(2): 1052-61, 2006 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16424041
8.
Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells.
Mol Cancer Ther
; 5(6): 1504-10, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16818509
9.
Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE).
Eur J Cancer
; 85: 133-145, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28923573
10.
RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial.
JAMA Oncol
; 3(2): 227-234, 2017 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27684533
11.
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer.
J Clin Oncol
; 33(12): 1334-9, 2015 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25559818
Resultados
1 -
11
de 11
1
Próxima >
>>